Inventor · disambiguated record
Xenia B. Searle
Also filed as: SEARLE XENIA · SEARLE XENIA B · SEARLE XENIA BEEBE
20 granted patents·13 pending applications·193 citations·filing 2000–2023
94Inventor score
Top patents by PatentIndex Score
33 records- 0196US9981910B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted May 29, 2018·31 cites·23 claims
- 0295US10118916B2Modulators of cystic fibrosis transmembrane conductance regulator proteinABBVIE SARL·Filed 2017·Granted Nov 6, 2018·30 cites·50 claims
- 0394US7030262B23-Amino-2-hydroxyalkanoic acids and their prodrugsABBOTT LAB·Filed 2003·Granted Apr 18, 2006·42 cites·4 claims
- 0492US6887863B2Hydrazide and alkoxyamide angiogenesis inhibitorsABBOTT LAB·Filed 2004·Granted May 3, 2005·32 cites·40 claims
- 0591US9642831B2Substituted chromanes and method of useABBVIE S Á R L·Filed 2015·Granted May 9, 2017·7 cites·69 claims
- 0691US7135484B2Azabicyclic compounds are central nervous system active agentsABBOTT LAB·Filed 2003·Granted Nov 14, 2006·26 cites·5 claims
- 0784US10399940B2Substituted pyrrolidines and methods of useABBVIE SARL·Filed 2017·Granted Sep 3, 2019·4 cites·21 claims
- 0882US10428017B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE SARL·Filed 2018·Granted Oct 1, 2019·1 cites·19 claims
- 0981US9567322B2Substituted tetrahydropyrans and method of useABBVIE S Á R L·Filed 2015·Granted Feb 14, 2017·4 cites·98 claims
- 1079US10988454B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2018·Granted Apr 27, 2021·1 cites·1 claims
- 1179US9840513B2Substituted tricyclics and method of useABBVIE S À R L·Filed 2016·Granted Dec 12, 2017·3 cites·68 claims
- 1276US8129417B2Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockersSTEWART ANDREW O·Filed 2009·Granted Mar 6, 2012·6 cites·20 claims
- 1373US8691865B2Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockersSEARLE XENIA B·Filed 2011·Granted Apr 8, 2014·4 cites·23 claims
- 1472US2021238159A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE OVERSEAS SARL·Filed 2021·Application pending·0 cites
- 1571US10844042B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1671US10844041B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 24, 2020·0 cites·2 claims
- 1771US10829473B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Nov 10, 2020·0 cites·2 claims
- 1869US10981890B2Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of useABBVIE OVERSEAS SARL·Filed 2020·Granted Apr 20, 2021·0 cites·1 claims
- 1963US7196200B2Antibacterial compoundsABBOTT LAB·Filed 2004·Granted Mar 27, 2007·2 cites·7 claims
- 2063US2019127356A1Substituted Chromanes and Method of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 2160US2017190693A1Substituted chromanes and method of useABBVIE S À R L·Filed 2017·Application pending·0 cites
- 2259US2024158368A1Pyrrolidine Main Protease Inhibitors as Antiviral AgentsABBVIE INC·Filed 2023·Application pending·0 cites
- 2358US7737159B2Antibacterial compoundsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·0 cites·5 claims
- 2457US2019135827A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 2555US2018244611A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE SARL·Filed 2018·Application pending·0 cites
- 2654US2006287290A1Azabicyclic compounds are central nervous system active agentsDART MICHAEL J·Filed 2006·Application pending·0 cites
- 2754US2018037587A1Substituted Tricyclics and Method of UseABBVIE SARL·Filed 2017·Application pending·0 cites
- 2853US2019315687A1Substituted Pyrrolidines and Methods of UseABBVIE SARL·Filed 2019·Application pending·0 cites
- 2948US2004014691A19-Oxime macrolide antibacterialsSEARLE XENIA BEEBE·Filed 2003·Application pending·0 cites
- 3045US2022211692A1Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of UseABBVIE GLOBAL ENTPR LTD·Filed 2021·Application pending·0 cites
- 3140US2004044029A1Azabicyclic compounds are central nervous system active agentsFiled 2002·Application pending·0 cites
- 3239US2003073850A14-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their useFiled 2000·Application pending·0 cites
- 3336US8796470B2Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulatorsSEARLE XENIA B·Filed 2011·Granted Aug 5, 2014·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Xenia B. Searle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →